Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ASML LEGAL NEWS: BFA Law Announces That a Class Action Lawsuit has Been filed Against ASML Holding N.V. and Urges Investors with Losses to Contact the Firm
-
Ethema Completes Acquisition of Kentucky Treatment Operations
-
HFSA and Elsevier Announce Inaugural Editor-in-Chief of New Journal of Cardiac Failure-Intersections
-
Issue of Equity and Total Voting Rights
-
Joint Stock Company Kaspi.kz Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court f
-
Venu Holding Corporation to Ring Opening Bell at New York Stock Exchange, Celebrating Bold Fan-Founded and Fan-Owned Mission
-
High Roller Technologies Welcomes Kristofer Muscat as Chief Operating Officer
-
TD SYNNEX Reports Fiscal 2024 Fourth Quarter and Full Year Results
-
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
-
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
-
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
-
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
-
BTCS Launches Innovative Staker Protection Plan
-
TrailRunner International Announces New Leadership Appointments
-
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club
-
NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
-
Is Spring Break 2025 the Most Expensive Yet? Here's What You Need to Know
-
LongPoint Announces a Filing of the Preliminary Prospectus for Return Stacked Global Balanced & Macro ETF ("RGBM")
-
Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer
-
EllisDon’s Executive Chair, Geoff Smith, Honoured with the 2025 Toronto Region Builder Award
-
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases
-
Diamond Lake Minerals (OTC: DLMI) Acquires Solutions™ Naturopathic & SoftWave Acupuncture Clinics to Pioneer Nationwide Expansion of Non-Invasive Medical Treatments
-
Elektros Expands AI Data Center Initiative with Focus on Small Language Models and Vector Databases
-
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations
-
Volcon MN1 Unit Arrives at Cycle Plaza Corpus Christi, Ready to Sell
-
Totus Medicines Announces Successful Completion of a Phase 1 Dose-Escalation Study and Initiation of an Expansion Trial Evaluating TOS-358, a Covalent PI3Ka Selective Therapy for the Treatment of Sele
-
RESTEM Provides Corporate Update and Announces Key Business Objectives for 2025
-
Park Aerospace Corp. Announces Date of Third Quarter Earnings Release and Conference Call
-
Hurco Reports Fourth Quarter and Full Year Results for Fiscal Year 2024
-
Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
-
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
-
Nusano Announces Isotope Availability
-
ORYZON to Provide Corporate Progress Updates at Several Events in January-February
-
XPPen Unveils Artist Pro 22 (Gen 2) with 2.5 K High-Performance 22-inch Drawing Display
-
Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
-
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering
-
Main Street Financial Services Corp. Declares Quarterly Dividend
-
Nano Labs Subsidiary Nano bit and BitFi Enter Strategic Partnership to Revolutionize Bitcoin Asset Management
-
Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress
-
Triller Saves Creators' TikTok Content Ahead of Ban
-
Breaking Stereotypes: New 3Fun Survey Reveals Media's Missteps in Polyamory Representation
-
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
-
Pipe17 Raises Series A, Brings on First COO As Demand for AI-Powered Order Operations Takes Off
-
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
-
KORE Recognized for Connected Vehicle Innovation in 2025 IoT Breakthrough Awards Program
-
Verismo Therapeutics Announces First Patient Infused in Phase 1 CELESTIAL-301 Clinical Trial of SynKIR™-310
-
Diakonos Oncology to Present at Biotech Showcase 2025
-
BofA's Consumer Investments Surpasses $500 Billion in Assets as Clients Choose High-Tech, High Touch Approach to Managing Finances
-
Trumid Reports December and Full Year 2024 Trading Highlights
